Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | RARB | P10826 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5684373 | 0.91 | CNR2 (0.45) | HSD11B1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL7607075 | 0.89 | CNR1 (0.50) | HSD11B1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL5687199 | 0.88 | CNR1 (0.52) | HSD11B1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL5684217 | 0.88 | CNR1 (0.52) | HSD11B1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL28947368 | 0.88 | CNR1 (0.52) | HSD11B1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL9153794 | 0.86 | RARB (0.51) | ALDH1A1TSHRMEN1KMT2ASLC6A4 | |
| Hydrochloric Acid SCHEMBL11524179 | 0.84 | RARB (0.50) | ALDH1A1TSHRMEN1KMT2ASLC6A4 | |
| SCHEMBL12002346 | 0.80 | ESR1 (0.52) | HSD11B1SLC6A4SLC6A2SLC6A3CNR1 | |
| SCHEMBL28326502 | 0.79 | CNR2 (0.46) | HSD11B1POLBMEN1KMT2ACNR1 | |
| SCHEMBL2089640 | 0.79 | SLC6A4 (0.59) | SLC6A4SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1375627-B1 | Optically active compound and liquid crystal composition containing the same | MITSUBISHI GAS CHEMICAL CO (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-6699532-B2 | CHIRAL DOPANT HAVING A HELICAL TWISTING POWER (HTP) OF AT LEAST 50 AND HAVING ITS INDUCED HELICAL PITCH DECREASING IN LENGTH WITH AN INCREASE IN TEMPERATURE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-03-02 | — | — | US | disclosed |
| US-20040007691-A1 | OPTICALLY ACTIVE COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-01-15 | — | — | US | disclosed |
| EP-1375627-A1 | Optically active compound and liquid crystal composition containing the same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040007691-A1 | OPTICALLY ACTIVE COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE COMPOUND | TOP1, ROCK1, SFRP1 | HSD11B1 46/4885ALDH1A1 2886/4885LMNA 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.